Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2004

Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen D-, et al. Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res. 2004;10(3):828-39.

Agostini M, Silva SD, Zecchin KG, Coletta RD, Jorge J, Loda M, et al. Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells. Oral Oncol. 2004;40(7):728-35.

Sboner A, Bauer P, Zumiani G, Eccher C, Blanzieri E, Forti S, et al. Clinical validation of an automated system for supporting the early diagnosis of melanoma. Skin Res Technol. 2004;10(3):184-92.

Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med. 2004;10(6):594-601.

Paik J-, Skoura A, Chae S-, Cowan AE, Han DK, Proia RL, et al. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev. 2004;18(19):2392-403.

Fiorucci S, Distrutti E, Mencarelli A, Rizzo G, Di Lorenzo AR, Baldoni M, et al. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence. J Pharmacol Exp Ther. 2004;309(3):1174-82.

Jiménez M, de Castro IP, Benet M, García JF, Inghirami G, Pellicer A. The Rgr oncogene induces tumorigenesis in transgenic mice. Cancer Res. 2004;64(17):6041-9.

Kaimaktchiev V, Terracciano L, Tornillo L, Spichtin H, Stoios D, Bundi M, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol. 2004;17(11):1392-9.

Di Bartolo D, Cesarman E. Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysis. Genome Biol. 2004;5(11):247.

Montgomery E, Abraham SC, Fisher C, Deasel MR, Amr SS, Sheikh SS, et al. CD44 loss in gastric stromal tumors as a prognostic marker. Am J Surg Pathol. 2004;28(2):168-77.